|IRB13-1469||Phase I, Open-Label, Safety, Tolerability, and Immunogenicity Study of VGX-3100 and INO-9012 Delivered by Electroporation (EP) in Women With Cervical Cancer After Chemoradiation
|16682B||Long Term Database Collection for Cervical Cancer
|12-1039||GOG 274: A Phase III Trial of Adjuvant Chemotherapy as Primary Treatment for
Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The Outback Trial
(ANZGOG 0902/GOG-0274/RTOG 1174)
|IRB14-0081||Phase I, Multicenter, Cohort Dose Escalation Trial to Determine the Safety, Tolerance, and Maximum Tolerated Dose of DCR-MYC, a Lipid Nanoparticle (LNP)-Formulated Small Inhibitory RNA (siRNA) Oligonucleotide Targeting MYC, in Patients with Refractory Locally Advanced or Metastatic Solid Tumor Malignancies, Multiple Myeloma, or Lymphoma
To learn more about cancer clinical trials or to make an appointment, call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials). Although our objective is to provide an updated listing of clinical trials, please note that a listing here does not guarantee that a trial is open or available to any specific patient. Additional trials may be available that are not listed. Complete information is available only from a treating physician.